These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7605505)

  • 21. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocked D phenomenon.
    Lee E
    Blood Transfus; 2013 Jan; 11(1):10-1. PubMed ID: 22790264
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immune conflict pregnancy caused by allosensitization to minor erythrocytic rhesus determinants].
    Morokov VA
    Akush Ginekol (Mosk); 1993; (3):53-5. PubMed ID: 7519414
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical significance of anti-G in alloimmunized pregnant women.
    Hadley A; Poole J; Poole G
    Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
    [No Abstract]   [Full Text] [Related]  

  • 26. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
    Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
    Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transient appearance of anti-erythrocyte autoantibodies during Rh alloimmunization].
    Alcorta I; Terol MJ; López-Guillermo A; Pereira A; Ordinas A
    Sangre (Barc); 1993 Aug; 38(4):323-6. PubMed ID: 8235947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemolytic disease of the newborn caused by anti-c antibodies. Case report].
    Ornat K; Cyran T; Maszkiewicz W
    Acta Haematol Pol; 1988; 19(1-2):75-6. PubMed ID: 3149114
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 33. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Important variations of maternal anti-Rhesus (D) antibody level during two consecutive pregnancies without antigenic stimulus.
    Moncharmont P; Juron-Dupraz F; Rigal D; Meyer F
    Acta Haematol; 1990; 83(2):105-6. PubMed ID: 2106193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
    Huchet J; Brossard Y
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 38. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Partial D' women with anti-D alloimmunization in pregnancy.
    Mayne KM; Allen DL; Bowell PJ
    Clin Lab Haematol; 1991; 13(3):239-44. PubMed ID: 1724416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.